| |
|
Drug Manufacturers - Other News
|
DOJ subpoenas documents on Forest Labs' inhalation drug
Fri 2:15 pm ET (Reuters)
Drugmaker Forest Laboratories received a subpoena earlier this month from U.S. prosecutors requesting documents relating to its small-selling lung disorder product, the Tudorza Pressair inhaler, the company ...
|
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 133B | | Price
/ Earnings: | 42.1 | | Price
/ Book: | 32.3 | | Net
Profit Margin (mrq): | 5.5% | | Price
To Free Cash Flow (mrq): | 44.3 | | Return
on Equity: | 6.0% | | Total
Debt / Equity: | 27.3 | | Dividend
Yield: | 1.4% |
|